Comparison of the analgesic efficacy of neosaxitoxin and bupivacaine for the prevention of postoperative pain in patients undergoing laparoscopic surgery for gallbladder removal.

Trial Profile

Comparison of the analgesic efficacy of neosaxitoxin and bupivacaine for the prevention of postoperative pain in patients undergoing laparoscopic surgery for gallbladder removal.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2011

At a glance

  • Drugs Neosaxitoxin (Primary) ; Bupivacaine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2011 Primary endpoint 'incisional pain 12 hours postoperatively, assessed by visual analogue scale pain scores' has been met.
    • 01 Apr 2011 Results published in Regional Anesthesia and Pain Medicine.
    • 25 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top